{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T03:04:50Z","timestamp":1769051090425,"version":"3.49.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,9]]},"abstract":"<jats:p>Immunocompromised subjects are at risk of severe viral infections which may require intensive care unit (ICU) admission. Data on the outcome of influenza pneumonia in critically-ill immunocompromised subjects are limited. We conducted a single-center observational study. All subjects admitted to the ICU for influenza pneumonia between 2016 and 2020 were included. The main objective was to compare the clinical features and outcome of critically-ill subjects with flu according to their immune status. 137 subjects (age 60 years-old, 58.4% male) were included, of whom 58 (42.34%) were intubated during the ICU stay. Forty-three (31.4%) subjects were immunocompromised. Immunocompromised subjects had a higher Charlson comorbidity index. In contrast, severity scores and hypoxemia at ICU admission, and ventilatory support during ICU stay were similar between the 2 groups. There was no difference in the rate of co-infections and ventilator-associated pneumonia between the 2 groups. Among intubated subjects, 10 (23.26%) immunocompromised subjects developed severe acute respiratory distress syndrome compared to 13 (13.83%) non-immunocompromised (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.218). ICU mortality was 13.97%, with mortality being 3-times higher in immunocompromised subjects (25.58% vs 8.6%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.015). On multivariable analysis, immunocompromised status, higher age and lower arterial oxygen partial pressure\/fraction of inspired oxygen were associated with an increased ICU mortality. Immunocompromised subjects with severe influenza pneumonia were more likely to develop severe acute respiratory distress syndrome and had a 3-fold increase in ICU mortality compared to non-immunocompromised subjects. Such difference was not explained by an increased rate of co-infections or nosocomial pneumonia, suggesting that influenza virus was by itself responsible of a more severe form of pulmonary disease in immunocompromised subjects.<\/jats:p>","DOI":"10.1097\/md.0000000000032245","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T21:39:00Z","timestamp":1673559540000},"page":"e32245","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Clinical features and outcome of influenza pneumonia in critically-ill immunocompromised patients"],"prefix":"10.1097","volume":"101","author":[{"given":"Matthieu","family":"Raymond","sequence":"first","affiliation":[{"name":"Service de M\u00e9decine Intensive R\u00e9animation, CHU de Nantes, Nantes Universit\u00e9, Jean Monnet, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u00eblle","family":"Martin","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive R\u00e9animation, CHU de Nantes, Nantes Universit\u00e9, Jean Monnet, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Lamouche-Wilquin","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive R\u00e9animation, CHU de Nantes, Nantes Universit\u00e9, Jean Monnet, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gauthier","family":"Blonz","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive R\u00e9animation, CHU de Nantes, Nantes Universit\u00e9, Jean Monnet, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Decamps","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive R\u00e9animation, CHU de Nantes, Nantes Universit\u00e9, Jean Monnet, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u00eft\u00e9","family":"Agbakou","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive R\u00e9animation, CHU de Nantes, Nantes Universit\u00e9, Jean Monnet, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Desmedt","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive R\u00e9animation, CHU de Nantes, Nantes Universit\u00e9, Jean Monnet, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Reignier","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive R\u00e9animation, CHU de Nantes, Nantes Universit\u00e9, Jean Monnet, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Baptiste","family":"Lascarrou","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive R\u00e9animation, CHU de Nantes, Nantes Universit\u00e9, Jean Monnet, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2143-8082","authenticated-orcid":false,"given":"Emmanuel","family":"Canet","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive R\u00e9animation, CHU de Nantes, Nantes Universit\u00e9, Jean Monnet, France."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"f5061","DOI":"10.1136\/bmj.f5061","article-title":"Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis.","volume":"347","author":"Mertz","year":"2013","journal-title":"BMJ"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy866","article-title":"Clinical practice guidelines by the infectious Diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa.","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/cid\/cit725","article-title":"The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts.","volume":"58","author":"Memoli","year":"2014","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/cid\/ciz638","article-title":"Outcomes of immunocompromised adults hospitalized with laboratory-confirmed influenza in the United States, 2011-2015.","volume":"70","author":"Collins","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet Lond Engl"},{"key":"R9-20250504","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin Definition.","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients.","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1001\/jama.2016.16477","article-title":"Prevalence of immunosuppression among US adults, 2013.","volume":"316","author":"Harpaz","year":"2016","journal-title":"JAMA"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1038\/cti.2014.3","article-title":"Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation.","volume":"3","author":"Fern\u00e1ndez-Ruiz","year":"2014","journal-title":"Clin Transl Immunol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1136\/annrheumdis-2015-207841","article-title":"Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance.","volume":"74","author":"Winthrop","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.blre.2015.04.002","article-title":"Managing critically ill hematology patients: time to think differently.","volume":"29","author":"Azoulay","year":"2015","journal-title":"Blood Rev"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1001\/jamaoncol.2015.2855","article-title":"Risk of critical illness among patients with solid cancers: a population-based observational study.","volume":"1","author":"Puxty","year":"2015","journal-title":"JAMA Oncol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017.","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 5","key":"R17-20250504","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1093\/cid\/ciu592","article-title":"Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies.","volume":"59","author":"Morrison","year":"2014","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/cid\/ciu104","article-title":"Beyond tumor necrosis factor inhibition: the expanding pipeline of biologic therapies for inflammatory diseases and their associated infectious sequelae.","volume":"58","author":"Novosad","year":"2014","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.chest.2016.01.002","article-title":"The critically ill kidney transplant recipient: a narrative review.","volume":"149","author":"Canet","year":"2016","journal-title":"Chest"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1378\/chest.14-3098","article-title":"Outcomes in critically ill patients with systemic rheumatic disease: a multicenter study.","volume":"148","author":"Dumas","year":"2015","journal-title":"Chest"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00134-017-4947-1","article-title":"Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study.","volume":"43","author":"Azoulay","year":"2017","journal-title":"Intensive Care Med"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcrc.2018.08.017","article-title":"Clinical characteristics, evolution, and treatment-related risk factors for mortality among immunosuppressed patients with influenza A (H1N1) virus admitted to the intensive care unit.","volume":"48","author":"Garnacho-Montero","year":"2018","journal-title":"J Crit Care"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10096-011-1346-3","article-title":"Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection.","volume":"31","author":"Cordero","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/CCM.0b013e3182416f23","article-title":"Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States.","volume":"40","author":"Rice","year":"2012","journal-title":"Crit Care Med"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/irv.12398","article-title":"The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis.","volume":"10","author":"Klein","year":"2016","journal-title":"Influenza Other Respir Viruses"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1378\/chest.10-1396","article-title":"Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus.","volume":"139","author":"Mart\u00edn-Loeches","year":"2011","journal-title":"Chest"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00134-016-4578-y","article-title":"Increased incidence of co-infection in critically ill patients with influenza.","volume":"43","author":"Martin-Loeches","year":"2017","journal-title":"Intensive Care Med"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/CCM.0000000000004861","article-title":"The extent of aspergillosis in critically ill patients with severe influenza pneumonia: a multicenter cohort study.","volume":"49","author":"Coste","year":"2021","journal-title":"Crit Care Med"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00134-021-06431-0","article-title":"Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.","volume":"47","author":"Vanderbeke","year":"2021","journal-title":"Intensive Care Med"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s10096-016-2703-z","article-title":"Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP\/CAP study.","volume":"36","author":"Koulenti","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13054-019-2425-6","article-title":"Influenza and associated co-infections in critically ill immunosuppressed patients.","volume":"23","author":"Martin-Loeches","year":"2019","journal-title":"Crit Care Lond Engl"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13054-019-2491-9","article-title":"Influenza virus-related critical illness: prevention, diagnosis, treatment.","volume":"23","author":"Chow","year":"2019","journal-title":"Crit Care"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:46:43Z","timestamp":1746334003000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":30,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032245","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]}}}